Results 121 to 130 of about 12,365 (224)

Intraoperative Collapse During First-Trimester Abortion: Hyperleukocytosis Crisis, Thrombotic Pulmonary Embolism, or Amniotic Fluid Embolism?

International Journal of Women's Health
Tingting Wen, Yu Zhang, Yushan Zhong, Shengwen SongDepartment of Anesthesiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of ChinaCorrespondence: Tingting Wen, Department of ...
Wen T, Zhang Y, Zhong Y, Song S
doaj  

Fertility preservation and subsequent reproductive outcomes in female pediatric patients with hematologic malignancies. [PDF]

Front Endocrinol (Lausanne)
Salvagno F, Evangelisti B, Agù M, Aprile R, Canosa S, Paschero C, Silvestris E, Corrado G, Gennarelli G, Revelli A.   +9 more
europepmc   +1 more source

Hydroxyurea (hydroxycarbamide) use in adults with haemoglobin SC disease: A real‐world study in Quebec

British Journal of Haematology, EarlyView.
Summary Haemoglobin SC (HbSC) disease is the second most prevalent form of sickle cell disease, but evidence for hydroxyurea (hydroxycarbamide; HU) to prevent pain episodes was limited until the prospective identification of variables as outcomes for treatment (PIVOT) trial.
Alice Girard, Laurianne Charette, Mélissa Haouchine, Laurence Bozec, Mohamed Zakaria Bachir Bouyadjera, Mariane Poitras, Vincent‐Thierry Taillefer, Chloé Trudeau, Yves Pastore, Nathalie Letarte, Stéphanie Forté   +10 more
wiley   +1 more source

Methaemoglobinaemia: From pathophysiology to contemporary clinical management

British Journal of Haematology, EarlyView.
Summary Methaemoglobin (MetHb) is an oxidised form of haemoglobin (Hb) unable to bind oxygen. Raised levels of MetHb reduce the blood's oxygen‐carrying capacity, causing potentially severe hypoxaemia and possible death. The condition arises from three main pathologies: mutations in globin genes causing Haemoglobin‐M, inherited deficiency of the enzyme ...
Alexander J. Twine, David C. Rees
wiley   +1 more source

Causal link between maternal PCOS and fetal/neonatal hemorrhagic and hematological disorders: A 2-sample MR study. [PDF]

Medicine (Baltimore)
Yang C, Song W, Lu K, Dang W, Feng J, Li Y, Li L, Zhang F, Liu L, Wu X.   +9 more
europepmc   +1 more source

Variation in antenatal anaemia guidelines across the NHS in the United Kingdom: A cross‐sectional study

British Journal of Haematology, EarlyView.
Summary Antenatal anaemia affects up to 30% of pregnant women in the United Kingdom and is a recognised clinical priority. National management guidance is published by the British Society of Haematology (BSH), but the extent to which local National Health Service (NHS) guidelines align with it is unknown.
Sarah Haynes, Islam Balboula, Peter Collins, William Parry‐Smith, Haddy Fye, Amy Elsmore, Rachel Collis, Lucy De Lloyd, David Churchill, Sarah F. Bell, Simon J. Stanworth   +10 more
wiley   +1 more source

Postpartum acquired hemophilia A: immunopathogenesis, diagnostic challenges, and treatment with the CyDRi protocol. [PDF]

Pathol Oncol Res
Szappanos Á, Andrikovics H, Varga P, Fekete M, Fazekas-Pongor V, Lehoczki M, Király V, Vilimi B, Mikala G, Bodó I, Ceglédi A.   +10 more
europepmc   +1 more source

INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol

BJU International, EarlyView.
Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease.
Ruby Lister‐Whelan, Ethan Senior, Jessica Kendall, Jamie B. Oughton, Fiona Collinson, Jon Griffin, Rachel Hubbard, Steven Kennish, Aidan Noon, Derek J. Rosario, Irbaz B. Riaz, Julie Telliez, James W. F. Catto, Syed A. Hussain   +13 more
wiley   +1 more source

A rare case of pregnancy-associated thrombotic thrombocytopenic purpura. [PDF]

Oxf Med Case Reports
Elmezayen ZW, Samara E, Zayed A, Hamed T.   +3 more
europepmc   +1 more source

Prospective Trial on Tolerability and Efficacy of Adjuvant Nedaplatin Plus Docetaxel for Non‐Small Cell Lung Cancer

Cancer Science, EarlyView.
The flow of this trial and the treatment schedule of adjuvant chemotherapy with nedaplatin plus docetaxel for completely resected non‐small cell lung cancer (NSCLC) (A). The primary endpoint of this study was tolerability, assessed by the completion rate of the planned four chemotherapy cycles. As a result, it was 74.3%, exceeding that reported for the
Koji Teramoto, Ryosuke Kaku, Tomoyuki Igarashi, Masayuki Hashimoto, Shoji Kitamura, Makoto Motoishi, Yuji Suzumura, Satoru Sawai, Yataro Daigo, Jun Hanaoka   +9 more
wiley   +1 more source